These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6977524)

  • 1. The contribution of beta-lactamases to beta-lactam resistance in Bacteroides fragilis.
    Simpson IN; Page CD; Harper PB
    J Antimicrob Chemother; 1982 Jan; 9(1):29-45. PubMed ID: 6977524
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on beta-lactamase in Bacteroides fragilis.
    Nord CE; Dornbusch K; Olsson B
    Infection; 1980; 8 Suppl 2():S167-70. PubMed ID: 6969692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamases in anaerobic bacteria.
    Nord CE; Lindqvist L; Olsson-Liljequist B; Tunér K
    Scand J Infect Dis Suppl; 1985; 46():57-63. PubMed ID: 3877980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.
    Mastrantonio P; Spigaglia P; Sebastianelli A
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):475-80. PubMed ID: 7957267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C; Dubreuil L; Sedallian A; Romond C
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of three different beta-lactamases from the Bacteroides fragilis group.
    Olsson-Liljequist B; Dornbusch K; Nord CE
    Antimicrob Agents Chemother; 1980 Aug; 18(2):220-5. PubMed ID: 6969573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
    Maskell JP; Nasu M; Williams JD
    J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-plasmid mediated transfer of beta-lactam resistance in Bacteroides fragilis.
    Yamaoka K; Watanabe K; Muto Y; Katoh N; Ueno K; Tally FP
    J Antibiot (Tokyo); 1990 Oct; 43(10):1302-6. PubMed ID: 2258328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.
    Dornbusch K; Olsson-Lijequist B; Nord CE
    J Antimicrob Chemother; 1980 Mar; 6(2):207-16. PubMed ID: 6966626
    [No Abstract]   [Full Text] [Related]  

  • 11. Properties of novel beta-lactamase produced by Bacteroides fragilis.
    Yotsuji A; Minami S; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1983 Dec; 24(6):925-9. PubMed ID: 6607033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
    Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
    J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical properties and purification of metallo-beta-lactamase from Bacteroides fragilis.
    Bandoh K; Muto Y; Watanabe K; Katoh N; Ueno K
    Antimicrob Agents Chemother; 1991 Feb; 35(2):371-2. PubMed ID: 1902649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.
    Cuchural GJ; Malamy MH; Tally FP
    Antimicrob Agents Chemother; 1986 Nov; 30(5):645-8. PubMed ID: 3492173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new potent beta-lactamase inhibitor, BRL 42715, with inherent activity against Bacteroides fragilis group strains.
    Aldridge KE
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S335-8. PubMed ID: 8324143
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
    Werner RG; Appel KR; Erne AM
    Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.
    Hurlbut S; Cuchural GJ; Tally FP
    Antimicrob Agents Chemother; 1990 Jan; 34(1):117-20. PubMed ID: 2327745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.